MACULAR DEGENERATION
Clinical trials for MACULAR DEGENERATION explained in plain language.
Never miss a new study
Get alerted when new MACULAR DEGENERATION trials appear
Sign up with your email to follow new studies for MACULAR DEGENERATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New eye injection aims to halt blinding disease
Disease control OngoingThis study is testing a new drug called AVD-104, given as an injection into the eye, for people with geographic atrophy (GA), a severe form of age-related macular degeneration that causes progressive vision loss. The main goal is to see if the drug is safe and if it can slow down…
Matched conditions: MACULAR DEGENERATION
Phase: PHASE2 • Sponsor: Aviceda Therapeutics, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Eye implant could offer new hope for macular degeneration patients
Disease control OngoingThis study is testing a new drug called zifibancimig for people with wet age-related macular degeneration (AMD), a leading cause of vision loss. The drug is being given as eye injections and through a small, refillable implant placed in the eye. The main goals are to see if the d…
Matched conditions: MACULAR DEGENERATION
Phase: PHASE1, PHASE2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Scientists map how the brain rewires itself after vision loss
Knowledge-focused OngoingThis study aims to understand how the brain adapts when people lose their central vision, as happens in conditions like macular degeneration. Researchers will work with healthy young adults, using special displays to temporarily simulate vision loss and training exercises to see …
Matched conditions: MACULAR DEGENERATION
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Knowledge-focused
Last updated Apr 02, 2026 02:11 UTC